key: cord-0730008-olii1ngh authors: Bruneau, L; Lenclume, V; Maillot, A; Rousseau, A; Lagrange-Xélot, M; Allou, N; Gérardin, P title: Exhaustive assessment of Reunion Island inpatients with COVID-19 during the first wave date: 2021-10-24 journal: Infect Dis Now DOI: 10.1016/j.idnow.2021.10.005 sha: fb3660c04cdac443a6df62a4e32b6bf6140f87c6 doc_id: 730008 cord_uid: olii1ngh nan J o u r n a l P r e -p r o o f 3 been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors did not receive any specific grant for this research from funding agencies in the public, commercial, or not-for-profit sectors. On Reunion Island, a French overseas department of 860,000 inhabitants located in the Southwestern part of the Indian Ocean (SWIO), the first confirmed case of coronavirus disease 19 (COVID-19) was imported by March 11, 2020. Considering the intense air traffic, we hypothesized that importations would be a major source of COVID-19 cases on Reunion Island. It was even more likely given that high-level standard of care, regional organization and policies confer a central role to Reunion Island for receiving air-flight medical evacuations from the SWIO region (Mauritius, Madagascar, Mayotte, and The Comoros). So far, limited information is available to describe the characteristics of inpatients from insular tropical settings. The Reunionese population is still relatively young but yet strongly affected by obesity (11%), diabetes (9.8%), and dengue, raising fear of increasing severe COVID-19 infections [1] [2] [3] . The COVID-EPI retrospective cohort study was conducted within Félix Guyon University Hospital, the only referral facility allowed to treat patients with COVID-19 on Reunion Island. Between March 11 and May 10, 2020, we enrolled all consecutive COVID-19 inpatients either diagnosed by a positive SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) from a nasopharyngeal swab specimen or positive antibodies. We divided our study period into two periods: Stage-1 period (introduction of an emergent pathogen into the territory) for admissions between March 11 and March 24, 2020, and Stage-2 period (start of its autochthonous spread) between March 25 and May 10, 2020 (end of lockdown). Hospitalization policy changed to comply with national and local guidelines according to the stage of the outbreak. Consent to participate was obtained orally for each patient before enrolment in the cohort after written information had been handed out. Epidemiological, clinical, sociodemographic characteristics and outcomes were collected from electronic medical records. Length of stay was provided by the Medical Informatics Department, blood group by the French blood establishment, and health insurance status by the administrative department of the hospital. Clinical outcomes included the length of hospital stay, intensive care unit (ICU) admission, vital status at discharge [4] , type of discharge for patients discharged alive, readmission, and vital status on day 28 post admission. Out of 436 COVID-19 cases diagnosed on the island, 171 (39%) required hospitalization. Among these, 168 were enrolled in the COVID-EPI cohort. The median age of inpatients was 50 years (IQR: 35-63, range 3-86 years). Half were females, of whom five were pregnant. Eighty-two inpatients (50%) had one or more comorbidities (including age and obesity), 70 (43%) excluding age. The most common comorbidities were hypertension, obesity, and diabetes mellitus (Table 1) . Stage-2 inpatients were more likely autochthonous than Stage-1 inpatients. However, there were no significant differences between imported and autochthonous cases regarding age, comorbidities, severity of illness, and time from symptom onset to RT-PCR and from symptom onset to admission. Importantly, most imported cases (82%) were permanent residents of the island. Among 159 symptomatic people, the five most common symptoms at onset of illness were fever, dry cough, asthenia, myalgia, and headache. Median time between fever onset and apyrexia was 9 days (IQR: 6-13 days). Forty (23%) inpatients had a severe to critical COVID-19 presentation. There was a trend towards more severe forms of COVID-19 in Stage-2 compared with Stage-1 (p=0.059). None of the patients have been included in an interventional research study protocol ( Table 2 ). The median length of stay was seven days (IQR: 3-13 days). Seventeen (10%) patients required admission to the ICU. One patient died in the ICU, 12 days after admission (death attributable to COVID-19). He was an 82-year-old man with hypertension and chronic kidney failure, who had been medically evacuated from Mayotte Island. Evacuated patients from Mayotte or Comoros Islands (n=9) more frequently presented with comorbidities (89% vs 47%; p=0.034) and were more likely to be admitted to the ICU (33% vs 9%; p=0.050). Our data highlight the low severity of the illness on our territory during the first wave of the COVID-19 epidemic (low infection fatality rate: 0.6%). Several factors may influence SARS-CoV-2 severity here. First, COVID-19 severity can be modulated by age [5] . Compared to some other European hospital-based studies, our population was about 10 to 20 years younger [6] [7] [8] . People under 20 years of age represent 31% of the Reunionese population [9]. Second, the health service has never been overburdened. Postponement of non-urgent care was implemented in the hospital as soon as March 11, 2020 (6 days prior to the national lockdown), thus increasing hospital bed capacity. Treatment has evolved during this period according to new scientific knowledge. In addition, early diagnosis at the time of travel return and systematic monitoring during Stage-1 may have contributed to prevent progression to severe disease. We observed changes in the clinical presentation of COVID-19 over the study period and a non-significant trend towards more severe forms of the disease in the Stage-2 period that 7 could be explained by an increase in the virulence as the transmission rate grew [10]. However, this hypothesis must be counterbalanced by the fact that hospitalization policy has also evolved over time, voluntarily selecting comorbid and severe patients who consulted later in hospital during the Stage-2 period. This hospital-based study is one of the first to report exhaustive high-quality data about SARS-CoV-2 infection, from an insular tropical setting of the Indian Ocean. The study is still ongoing, which will allow us to follow the evolution of patients' characteristics, especially for the South Prévalence du diabète traité pharmacologiquement (tous types) en France en 2015. Disparités territoriales et socio-éconmiques COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obes Silver Spring Md. Epub ahead of print 9 The Glasgow Outcome Scale -40 years of application and refinement Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area -a retrospective cohort study. Epub ahead of print 14 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy All p-values refer to comparisons between the two periods using the Mann-Whitney U test for quantitative variables and the Chi 2 test or Fisher's exact test ( † ) or Fisher-Freeman-Halton test ( ‡ ) for categorical variables Acute Respiratory Distress Syndrome; NIV, Non-invasive ventilation Invasive mechanical ventilation; ICU, Intensive Care Unit This project would not have been possible without the kind support and assistance of many individuals, and we would like to extend our profound gratitude to each of them. We thank